Neurologist Jonathan Glass and neurosurgeon Nick Boulis of Emory University ask: Should acceptable risk levels for experimental treatments be recalibrated for the terminally ill who have no other options?
Skip to content
TEDMED is a global community dedicated to unlocking imagination in service of health and medicine.